If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Dyspepsia Dizziness Abdominal distension Eructation Hypoglycemia in patients with type 2 diabetes Flatulence Gastroenteritis Gastroesophageal reflux disease You are encouraged to report negative side effects of prescription products: Contact FDA MedWatch at 1-800-FDA-1088 or visit www.fda.gov/medwatch
Similar conformational change was also observed in the tirzepatideGIPRG s , tirzepatideGLP-1RG s , peptide 20GIPRG s and peptide 20GLP-1RG s complexes, compared to peptide-free apo GLP-1R structure 31
To keep it potent for future experiments and get the most out of your purchase, stick to these core principles